Recurrent Childhood Medulloblastoma Completed Phase 1 Trials for 6-O-benzylguanine (DB11919)

IndicationStatusPhase
DBCOND0028751 (Recurrent Childhood Medulloblastoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00052780Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsTreatment